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Dr Harry Schanzer (New York, NY). The paper just pre-
sented byDr Raju et al is extremely important because it challenges
all the previous concepts of pathogenesis and treatment of chronic
venous insufficiency. Dr Raju, you have really put upside down all
our previous notions of venous disease. I have carefully followed
your experience over the years. Initially, you reported excellent
results with valvular reconstruction even in the setting of postphle-
bitic syndrome. Later on, you reported improved results with iliac
vein stenting in the postphlebitic syndrome, and now you are
presenting us with the treatment of primary valvular venous insuf-
ficiency by iliac vein stenting. This, if true, is really a revolutionary
change in the conceptual understanding of the pathogenesis of
CVI and its treatment. I have two questions with regards to your
experience.
The first one is: you reported 90% of patients with primary
venous insufficiency having an obstruction of the iliac system as
determined by IVUS. I would like to know how significant is this
obstruction? In a control population with no CVI, how often
would you have these IVUS findings? How significant is this
finding?
The second question is: is there any additional therapy that
you use in these patients that can confuse the results of the
stenting? I specifically refer to elastic compression.
Finally, I think that it is very important to wait for corrobora-
tion of your results. These are very impressive, and if other groups
can reproduce them, this will change significantly the understand-
ing and treatment of venous insufficiency.
Dr Raju. It is clear from modern imaging techniques that
two-thirds of the normal population have obstructive iliac vein
lesions that are silent. IVUS detectable lesions are present in over
90% of patients with chronic venous disease with CEAP clinical
class 3 and higher presentation. Initially, we were worried that we
were treating something that is normally present; but the clinical
outcome, particularly healing of stasis ulceration, suggests that the
obstructive lesion is contributory to the disease process.
No new stockings are issued after stent placement. So, the
reported clinical improvement is due to the stent procedure itself.
Dr Mark Adelman (New York, NY). If you would, briefly
comment on your anticoagulation regimen and how you manage
these stents postimplantation. I imagine most of these patientsnegative, and they are not found to be hypercoagulable, how do
you manage the anticoagulation regimen over the long term?
Dr Raju. If the thrombophilia is absent, they just get aspirin
when they go home. If thrombophilia is present, warfarin is insti-
tuted or continued.
Dr Rabih Chaer (Pittsburgh, Pa). How do you define venous
stenosis on IVUS? What is your definition of a venous stenosis in
general? And what degree of stenosis do you treat with stenting?
Dr Raju. The normal iliac vein measures about 175 to 250 sq
mm. So you can measure the area with IVUS planimetry software
and compute the stenosis. Anything over 50% area stenosis appears
to be clinically significant.
Dr Peter Gloviczki (Rochester, Minn). This is a tremendous
experience, and as Dr Schanzer said, it changes a lot of what we
know about venous disease.
When we measured 23 limbs with venous reflux, we found
that it became worse in 24% after iliocaval stenting. Somy question
is: do you have a subgroup where you see worsening in venous
reflux?
Many patients who need iliac venous stenting also have in-
frainguinal venous reflux or post-thrombotic obstruction. It looks
like you are not recommending elastic compression after venous
stenting even in this group of patients. Could you tell us why not?
Dr Raju. Reflux does not get worse after stenting when the
data are analyzed in aggregate; in fact, there was a small but
significant improvement in VFI90 afterwards. We have not per-
formed intensive subset analysis to examine if this may not be the
case in some limbs.
Most patients that come to us have already gone through
compression programs. In about one-third of patients, compres-
sion is not appropriate because of local condition of the limb or
systemic deterrents to regular use. In others, compression is not
effective or not tolerated. Noncompliance with prescribed stock-
ings is a difficult and often incorrigible problem that we have dealt
with in a separate publication. We allow patients to maintain
current compression regimen (use or nonuse) without modifica-
tion near term after stent placement. Long term, they are allowed
to abandon stockings if it made no difference. Most patients
abandon stockings entirely or limit usage to only ”hard” days if
clinical outcome is successful.
